Yamamoto M, Hibi H, Miyake K
Department of Urology, Nagoya University School of Medicine, Japan.
Int Urol Nephrol. 1994;26(2):205-8. doi: 10.1007/BF02768288.
Twenty patients with testicular hydrocele were treated with a new sclerosing therapy consisting of intrascrotal injection of OK-432 (group A Streptococcus pyogenes of human origin). The median observation period after treatment was 6 months (range 2-13 months). Eighteen patients required only one treatment. Two patients had recurrences and received repeat injection. There have been no serious side effects except for fever of 2-3 days' duration and local inflammatory reaction. Sclerotherapy with OK-432 is an efficient and easy method which can be recommended as a primary treatment for hydrocele.
20例睾丸鞘膜积液患者接受了一种新的硬化治疗，该治疗方法是将OK-432（人源A组化脓性链球菌）注射到阴囊内。治疗后的中位观察期为6个月（范围2 - 13个月）。18例患者仅需接受一次治疗。2例患者复发并接受了重复注射。除了持续2 - 3天的发热和局部炎症反应外，未出现严重副作用。用OK-432进行硬化治疗是一种有效且简便的方法，可推荐作为鞘膜积液的主要治疗方法。
